Detwiler

Clever Leaves Announces Leadership Transition Plan

Retrieved on: 
Wednesday, February 9, 2022
Private Securities Litigation Reform Act, Pandemic, BOCA, GLOBE, Growth, Disclosure, Harvard Business School, Â, SEC, Risk, Strategy&, GACP, GAP, Xi, Business administration, Lists of disasters, Research, Company, Perception, EMEA, Knowledge, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., Detwiler, 100,000, Goal, Failure, LinkedIn, Fair Debt Collection Practices Act, NASDAQ, THC, Time, CBD, Patient, Economics, EU, Weather, COVID-19, Investment, GMP, Leadership, Certification, Leaf, CEO, Booz, Cannabis, History, Universidad de los Andes, WHO, Master of Business Administration, Forward-looking statement, Management, Science

BOCA RATON, Fla., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (Clever Leaves or the Company), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced a leadership transition plan.

Key Points: 
  • BOCA RATON, Fla., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (Clever Leaves or the Company), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced a leadership transition plan.
  • Prior to Clever Leaves, from 2016 to 2018, Fajardo was a founding partner of Mojo Ventures, a venture capital incubator in Colombia.
  • Clever Leaves was granted a license in Portugal from Infarmed the Portuguese health authority which allows Clever Leaves to cultivate, import and export dry flower for medicinal and research purposes.
  • All subsequent written and oral forward-looking statements concerning Clever Leaves and attributable to Clever Leaves or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above.

Schultze Special Purpose Acquisition Corp. and Clever Leaves International Inc., a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator, to Participate in Two Upcoming Investor Conferences

Retrieved on: 
Thursday, September 24, 2020
Detwiler, Sama, Airlines, Aviation

RYE BROOK, N.Y., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (SAMA) and Clever Leaves International Inc. (Clever Leaves) today announced that the companies will participate in two upcoming investor conferences.

Key Points: 
  • RYE BROOK, N.Y., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (SAMA) and Clever Leaves International Inc. (Clever Leaves) today announced that the companies will participate in two upcoming investor conferences.
  • On Thursday, October 8, 2020, the companies will be hosting one-on-one meetings with institutional investors at the Jefferies Cannabis Summit.
  • At 11:00 AM ET, Kyle Detwiler, CEO of Clever Leaves, will participate in a panel discussion titled International Markets: Growth Starting to Pick Up, But So is Competition.
  • Clever Leaves executive management team, led by Kyle Detwiler, CEO, and Andrs Fajardo, President, are expected to continue to lead the combined company.

Schultze Special Purpose Acquisition Corp. Announces a Definitive Agreement to Combine with Clever Leaves, a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator

Retrieved on: 
Monday, July 27, 2020
Agriculture, Natural Resources, Finance, Health, Specialty, Professional services, Retail, Other Health, Cannabis, Cannabis smoking, Entheogens, Euphoriants, Clever, Detwiler, Medical specialties, Clinical medicine, Medicine, Schultze Special Purpose Acquisition Corp., Clever Leaves International Inc.

Clever Leaves executive management team, led by Kyle Detwiler, Chief Executive Officer, and Andrs Fajardo, President, will continue to lead the combined company.

Key Points: 
  • Clever Leaves executive management team, led by Kyle Detwiler, Chief Executive Officer, and Andrs Fajardo, President, will continue to lead the combined company.
  • EU GMP certification is required in many instances to commercialize medical cannabis products in the EU and is expected to expand Clever Leaves ability to serve international markets.
  • George J. Schultze, Chairman and CEO of SAMA, said, We are incredibly excited to partner with Clever Leaves and look forward to consummating this transaction.
  • The transaction will be effected pursuant to the Business Combination Agreement entered into by SAMA and Clever Leaves.